138 related articles for article (PubMed ID: 37458164)
21. 3-Hydroxyacyl-CoA and Alcohol Dehydrogenase Activities of Mitochondrial Type 10 17β-Hydroxysteroid Dehydrogenase in Neurodegeneration Study.
He XY; Dobkin C; Brown WT; Yang SY
J Alzheimers Dis; 2022; 88(4):1487-1497. PubMed ID: 35786658
[TBL] [Abstract][Full Text] [Related]
22. Multiple functions of type 10 17beta-hydroxysteroid dehydrogenase.
Yang SY; He XY; Schulz H
Trends Endocrinol Metab; 2005; 16(4):167-75. PubMed ID: 15860413
[TBL] [Abstract][Full Text] [Related]
23. Levels of 17β-hydroxysteroid dehydrogenase type 10 in CSF are not a valuable biomarker for multiple sclerosis.
Kristofikova Z; Ricny J; Kaping D; Klaschka J; Kotoucova J; Bartos A
Biomark Med; 2018 Dec; 12(12):1331-1340. PubMed ID: 30520659
[TBL] [Abstract][Full Text] [Related]
24. Hydroxysteroid (17β) dehydrogenase X in human health and disease.
Yang SY; He XY; Miller D
Mol Cell Endocrinol; 2011 Aug; 343(1-2):1-6. PubMed ID: 21708223
[TBL] [Abstract][Full Text] [Related]
25. Study of Biomolecular Interactions of Mitochondrial Proteins Related to Alzheimer's Disease: Toward Multi-Interaction Biomolecular Processes.
Hemmerová E; Špringer T; Krištofiková Z; Homola J
Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32825572
[TBL] [Abstract][Full Text] [Related]
26. Friend or enemy? Review of 17β-HSD10 and its role in human health or disease.
Vinklarova L; Schmidt M; Benek O; Kuca K; Gunn-Moore F; Musilek K
J Neurochem; 2020 Nov; 155(3):231-249. PubMed ID: 32306391
[TBL] [Abstract][Full Text] [Related]
27. Oxidative 3alpha-hydroxysteroid dehydrogenase activity of human type 10 17beta-hydroxysteroid dehydrogenase.
He XY; Yang YZ; Peehl DM; Lauderdale A; Schulz H; Yang SY
J Steroid Biochem Mol Biol; 2003 Nov; 87(2-3):191-8. PubMed ID: 14672739
[TBL] [Abstract][Full Text] [Related]
28. Ionic Environment Affects Biomolecular Interactions of Amyloid-β: SPR Biosensor Study.
Hemmerová E; Špringer T; Krištofiková Z; Homola J
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33419257
[TBL] [Abstract][Full Text] [Related]
29. Effects of novel 17β-hydroxysteroid dehydrogenase type 10 inhibitors on mitochondrial respiration.
Fišar Z; Musílek K; Benek O; Hroch L; Vinklářová L; Schmidt M; Hroudová J; Raboch J
Toxicol Lett; 2021 Mar; 339():12-19. PubMed ID: 33359020
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and evaluation of frentizole-based indolyl thiourea analogues as MAO/ABAD inhibitors for Alzheimer's disease treatment.
Hroch L; Guest P; Benek O; Soukup O; Janockova J; Dolezal R; Kuca K; Aitken L; Smith TK; Gunn-Moore F; Zala D; Ramsay RR; Musilek K
Bioorg Med Chem; 2017 Feb; 25(3):1143-1152. PubMed ID: 28082069
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of 17β-hydroxysteroid dehydrogenase type 10 increases pheochromocytoma cell growth and resistance to cell death.
Carlson EA; Marquez RT; Du F; Wang Y; Xu L; Yan SS
BMC Cancer; 2015 Mar; 15():166. PubMed ID: 25879199
[TBL] [Abstract][Full Text] [Related]
32. Comparative evolutionary genomics of the HADH2 gene encoding Abeta-binding alcohol dehydrogenase/17beta-hydroxysteroid dehydrogenase type 10 (ABAD/HSD10).
Marques AT; Antunes A; Fernandes PA; Ramos MJ
BMC Genomics; 2006 Aug; 7():202. PubMed ID: 16899120
[TBL] [Abstract][Full Text] [Related]
33. 17β-Hydroxysteroid dehydrogenases and neurosteroid metabolism in the central nervous system.
He XY; Dobkin C; Yang SY
Mol Cell Endocrinol; 2019 Jun; 489():92-97. PubMed ID: 30321584
[TBL] [Abstract][Full Text] [Related]
34. [Molecular cloning, prokaryotic expression and double-antibody sandwich ELISA development of 17β-hsd10 in mouse].
Liu C; Niu Y; Chen Y; Wu C; Yu Y
Sheng Wu Gong Cheng Xue Bao; 2014 Nov; 30(11):1774-80. PubMed ID: 25985528
[TBL] [Abstract][Full Text] [Related]
35. Harnessing functional plasticity of enzymes: a fluorogenic probe for imaging 17beta-HSD10 dehydrogenase, an enzyme involved in Alzheimer's and Parkinson's diseases.
Froemming MK; Sames D
J Am Chem Soc; 2007 Nov; 129(46):14518-22. PubMed ID: 17958419
[TBL] [Abstract][Full Text] [Related]
36. Mutation or knock-down of 17β-hydroxysteroid dehydrogenase type 10 cause loss of MRPP1 and impaired processing of mitochondrial heavy strand transcripts.
Deutschmann AJ; Amberger A; Zavadil C; Steinbeisser H; Mayr JA; Feichtinger RG; Oerum S; Yue WW; Zschocke J
Hum Mol Genet; 2014 Jul; 23(13):3618-28. PubMed ID: 24549042
[TBL] [Abstract][Full Text] [Related]
37. ost in promiscuity? An evolutionary and biochemical evaluation of HSD10 function in cardiolipin metabolism.
Wohlfarter Y; Eidelpes R; Yu RD; Sailer S; Koch J; Karall D; Scholl-Bürgi S; Amberger A; Hillen HS; Zschocke J; Keller MA
Cell Mol Life Sci; 2022 Oct; 79(11):562. PubMed ID: 36271951
[TBL] [Abstract][Full Text] [Related]
38. 17β-Hydroxysteroid dehydrogenase type 10 predicts survival of patients with colorectal cancer and affects mitochondrial DNA content.
Amberger A; Deutschmann AJ; Traunfellner P; Moser P; Feichtinger RG; Kofler B; Zschocke J
Cancer Lett; 2016 Apr; 374(1):149-155. PubMed ID: 26884257
[TBL] [Abstract][Full Text] [Related]
39. Expanded substrate screenings of human and Drosophila type 10 17beta-hydroxysteroid dehydrogenases (HSDs) reveal multiple specificities in bile acid and steroid hormone metabolism: characterization of multifunctional 3alpha/7alpha/7beta/17beta/20beta/21-HSD.
Shafqat N; Marschall HU; Filling C; Nordling E; Wu XQ; Björk L; Thyberg J; Mårtensson E; Salim S; Jörnvall H; Oppermann U
Biochem J; 2003 Nov; 376(Pt 1):49-60. PubMed ID: 12917011
[TBL] [Abstract][Full Text] [Related]
40. Crystal structure of human ABAD/HSD10 with a bound inhibitor: implications for design of Alzheimer's disease therapeutics.
Kissinger CR; Rejto PA; Pelletier LA; Thomson JA; Showalter RE; Abreo MA; Agree CS; Margosiak S; Meng JJ; Aust RM; Vanderpool D; Li B; Tempczyk-Russell A; Villafranca JE
J Mol Biol; 2004 Sep; 342(3):943-52. PubMed ID: 15342248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
